. Author manuscript; available in PMC: 2015 Jul 6.

Published in final edited form as: Diabetologia. 2012 Sep 20;55(12):3359–3368. doi: 10.1007/s00125-012-2719-6

Table 3.

Determinants of baseline FCP levels from multivariate analyses, stratified by baseline DA status

Determinant	DA positive		DA negative
	Effect, % (95% CI)^a	p value	Effect, % (95% CI)^a	p value
Age at diagnosis (<10 vs ≥10 years)	44 (38, 49)	<0.0001	57 (47, 65)	<0.0001
Sex (male vs female)	11 (2, 19)	0.0185		0.1
Race (NHW vs others)	19 (9, 28)	0.0004	30 (15, 42)	0.0002
HLA (susceptible vs not susceptible)		0.7		0.5
Baseline HbA_1c (per 1% increase)	19 (15, 22)	<0.0001	7 (1, 13)	0.0170
Baseline BMI z score (per 1 unit decrease)	17 (13, 21)	<0.0001	37 (32, 42)	<0.0001

Percentage by which baseline FCP level is lower